

A/Prof. Dr. Alexander van Akkooi, MD, PhD, FRACS strives to deliver state of the art, top-class care. He is recognized as a world-leading expert surgical oncologist in the treatment of melanoma
and non-melanoma skin cancers.
A/Prof. Dr. Alexander van Akkooi has been awarded the 2025 Martin Gore Memorial Lecture Award for "Surgery for Melanoma – Its Present and Possible Future Roles". For his contribution to improve surgical treatments for melanoma patients.
It was a pleasure delivering 2 invited lectures at CMC2026 and connecting with my colleagues in Canada.
Key take aways:
Lecture 1 - The #SurgicalOncologist Perspective on #neoadjuvant #immunotherapy
1. Neoadjuvant immunotherapy is the novel standard of care for macroscopic stage III Melanoma.⚕️
2. Surgery for Melanoma continues to evolve. 🏥
3. Neoadjuvant immunotherapy does not impact on the surgical complications/outcomes. 📊
4. Teamwork and communication with all stakeholders is essential to deliver this state of the art multidisciplinary care. 👨⚕️👩⚕️🧑⚕️
5. The Multicenter Selective Lymphadenectomy Trial 3 (MSLT-3 / #SWOG S2601 / #EORTC 2519; NCT07049276). 📈
Helping patients is our core business, we aim to see all patients within no more than a week (nobody should ever wait more than 1 weekend to have their first consultation!)
Phone the offices today to make an appointment.
The Melanoma Institute of Australia, 40 Rocklands Rd., Sydney, New South Wales 2065, Australia
Open today | 09:00 am – 05:00 pm |









